Literature DB >> 25420158

Effective treatment of cerebral mucormycosis associated with brain surgery.

Omar Chamdine1, Aditya H Gaur, Alberto Broniscer.   

Abstract

Isolated cerebral mucormycosis is rare. We describe a patient with a brain tumor and a surgically-related Rhizopus oryzae brain abscess. Her abscess was effectively treated with posaconazole, micafungin and colony-stimulating factor followed by posaconazole alone. To our knowledge, cerebral mucormycosis secondary to brain surgery had not been previously reported.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25420158      PMCID： PMC4400195          DOI： 10.1097/INF.0000000000000626

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  10 in total

1.  Combination therapy for mucormycosis: why, what, and how?

Authors:  Brad Spellberg; Ashraf Ibrahim; Emmanuel Roilides; Russel E Lewis; Olivier Lortholary; George Petrikkos; Dimitrios P Kontoyiannis; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2012-02       Impact factor: 9.079

Review 2.  Epidemiology and outcome of zygomycosis: a review of 929 reported cases.

Authors:  Maureen M Roden; Theoklis E Zaoutis; Wendy L Buchanan; Tena A Knudsen; Tatyana A Sarkisova; Robert L Schaufele; Michael Sein; Tin Sein; Christine C Chiou; Jaclyn H Chu; Dimitrios P Kontoyiannis; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2005-07-29       Impact factor: 9.079

Review 3.  Pathogenesis of mucormycosis.

Authors:  Ashraf S Ibrahim; Brad Spellberg; Thomas J Walsh; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2012-02       Impact factor: 9.079

4.  A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007).

Authors:  F Lanternier; E Dannaoui; G Morizot; C Elie; D Garcia-Hermoso; M Huerre; D Bitar; F Dromer; O Lortholary
Journal:  Clin Infect Dis       Date:  2012-02       Impact factor: 9.079

5.  Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007.

Authors:  A Skiada; L Pagano; A Groll; S Zimmerli; B Dupont; K Lagrou; C Lass-Florl; E Bouza; N Klimko; P Gaustad; M Richardson; P Hamal; M Akova; J F Meis; J-L Rodriguez-Tudela; E Roilides; A Mitrousia-Ziouva; G Petrikkos
Journal:  Clin Microbiol Infect       Date:  2011-07-01       Impact factor: 8.067

6.  Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis.

Authors:  Ashraf S Ibrahim; Joel C Bowman; Valentina Avanessian; Keturah Brown; Brad Spellberg; John E Edwards; Cameron M Douglas
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

7.  Cerebral zygomycosis.

Authors:  C Sundaram; A Mahadevan; V Laxmi; T C Yasha; V Santosh; J M K Murthy; A K Purohit; S Mohandas; S K Shankar
Journal:  Mycoses       Date:  2005-11       Impact factor: 4.377

8.  Interferon- gamma and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important zygomycetes.

Authors:  Cristina Gil-Lamaignere; Maria Simitsopoulou; Emmanuel Roilides; Avgi Maloukou; Richard M Winn; Thomas J Walsh
Journal:  J Infect Dis       Date:  2005-02-25       Impact factor: 5.226

Review 9.  Mucormycosis treated with posaconazole: review of 96 case reports.

Authors:  Joerg J Vehreschild; Andrea Birtel; Maria J G T Vehreschild; Blasius Liss; Fedja Farowski; Matthias Kochanek; Michal Sieniawski; Angela Steinbach; Kerstin Wahlers; Gerd Fätkenheuer; Oliver A Cornely
Journal:  Crit Rev Microbiol       Date:  2012-08-24       Impact factor: 7.624

10.  ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013.

Authors:  O A Cornely; S Arikan-Akdagli; E Dannaoui; A H Groll; K Lagrou; A Chakrabarti; F Lanternier; L Pagano; A Skiada; M Akova; M C Arendrup; T Boekhout; A Chowdhary; M Cuenca-Estrella; T Freiberger; J Guinea; J Guarro; S de Hoog; W Hope; E Johnson; S Kathuria; M Lackner; C Lass-Flörl; O Lortholary; J F Meis; J Meletiadis; P Muñoz; M Richardson; E Roilides; A M Tortorano; A J Ullmann; A van Diepeningen; P Verweij; G Petrikkos
Journal:  Clin Microbiol Infect       Date:  2014-04       Impact factor: 8.067
  10 in total
  1 in total

Review 1.  Mucormycosis of the Central Nervous System.

Authors:  Amanda Chikley; Ronen Ben-Ami; Dimitrios P Kontoyiannis
Journal:  J Fungi (Basel)       Date:  2019-07-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.